Overview

A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia

Status:
Completed

Trial end date:
1996-12-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to compare the safety and efficacy of risperidone (an antipsychotic medication) to that of placebo in the treatment of behavioral disturbances associated with dementia.

Phase:

Phase 3

Details

Lead Sponsor:

Janssen Pharmaceutica N.V., Belgium

Treatments:

Risperidone